Light Mode
$1.06 ↑ +0.00 (+0.00%) Trading Up from the previous close of $1.06, and at the day’s high of $1.06
-2.06 (-66.03%) / 6M
Momentum, market sentiment, and recent alerts
LSTA reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -62.1%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. Its product, Certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate tumors. The company was founded in 1980 and is headquartered in Basking Ridge, NJ.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.